First Manhattan’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-26
| Closed | -$4.14K | – | 1616 |
|
|
2022
Q4 | $4.14K | Buy |
+26
| New | +$3.81K | ﹤0.01% | 1445 |
|
|
2021
Q1 | – | Sell |
-120
| Closed | -$19K | – | 1516 |
|
|
2020
Q4 | $19K | Hold |
120
| – | – | ﹤0.01% | 1061 |
|
|
2020
Q3 | $17K | Hold |
120
| – | – | ﹤0.01% | 1045 |
|
|
2020
Q2 | $13K | Sell |
120
-1,575
| -93% | -$174K | ﹤0.01% | 1116 |
|
|
2020
Q1 | $169K | Sell |
1,695
-325
| -16% | -$42K | ﹤0.01% | 651 |
|
|
2019
Q4 | $301K | Hold |
2,020
| – | – | ﹤0.01% | 617 |
|
|
2019
Q3 | $258K | Sell |
2,020
-700
| -26% | -$93.8K | ﹤0.01% | 640 |
|
|
2019
Q2 | $387K | Sell |
2,720
-1,000
| -27% | -$134K | ﹤0.01% | 584 |
|
|
2019
Q1 | $531K | Hold |
3,720
| – | – | ﹤0.01% | 550 |
|
|
2018
Q4 | $461K | Buy |
3,720
+1,000
| +37% | +$148K | ﹤0.01% | 571 |
|
|
2018
Q3 | $457K | Hold |
2,720
| – | – | ﹤0.01% | 592 |
|
|
2018
Q2 | $468K | Hold |
2,720
| – | – | ﹤0.01% | 557 |
|
|
2018
Q1 | $410K | Buy |
2,720
+120
| +5% | +$17.6K | ﹤0.01% | 562 |
|
|
2017
Q4 | $350K | Hold |
2,600
| – | – | ﹤0.01% | 605 |
|
|
2017
Q3 | $380K | Buy |
2,600
+700
| +37% | +$106K | ﹤0.01% | 572 |
|
|
2017
Q2 | $295K | Hold |
1,900
| – | – | ﹤0.01% | 608 |
|
|
2017
Q1 | $275K | Hold |
1,900
| – | – | ﹤0.01% | 629 |
|
|
2016
Q4 | $207K | Hold |
1,900
| – | – | ﹤0.01% | 657 |
|
|
2016
Q3 | $230K | Hold |
1,900
| – | – | ﹤0.01% | 643 |
|
|
2016
Q2 | $268K | Hold |
1,900
| – | – | ﹤0.01% | 628 |
|
|
2016
Q1 | $248K | Hold |
1,900
| – | – | ﹤0.01% | 627 |
|
|
2015
Q4 | $267K | Hold |
1,900
| – | – | ﹤0.01% | 621 |
|
|
2015
Q3 | $252K | Hold |
1,900
| – | – | ﹤0.01% | 621 |
|
|
2015
Q2 | $334K | Hold |
1,900
| – | – | ﹤0.01% | 595 |
|
|
2015
Q1 | $328K | Hold |
1,900
| – | – | ﹤0.01% | 597 |
|
|
2014
Q4 | $311K | Hold |
1,900
| – | – | ﹤0.01% | 609 |
|
|
2014
Q3 | $305K | Hold |
1,900
| – | – | ﹤0.01% | 613 |
|
|
2014
Q2 | $279K | Hold |
1,900
| – | – | ﹤0.01% | 627 |
|
|
2014
Q1 | $263K | Hold |
1,900
| – | – | ﹤0.01% | 638 |
|
|
2013
Q4 | $240K | Buy |
1,900
+200
| +12% | +$20.7K | ﹤0.01% | 642 |
|
|
2013
Q3 | $156K | Buy |
+1,700
| New | +$137K | ﹤0.01% | 704 |
|
Other funds holding JAZZ
PCM
DTC
First Manhattan's JAZZ Position: Q1 2023 in Review
First Manhattan sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2023, closing a stake of 26 shares — an estimated $4.14K sold.
First Manhattan first reported a position in JAZZ in Q3 2013 and held it in 31 quarters. The position peaked at $531K in Q1 2019. 471 funds tracked by Wall St. Rank hold JAZZ as of Q1 2023.
- First Manhattan reported no remaining Jazz Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
- First Manhattan sold 26 Jazz Pharmaceuticals shares in Q1 2023, an estimated $4.14K.
- First Manhattan first reported a position in Jazz Pharmaceuticals in Q3 2013 and held it in 31 quarters.
- First Manhattan's Jazz Pharmaceuticals position peaked at $531K in Q1 2019.
- 471 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2023.
Based on First Manhattan's 13F filing for Q1 2023, filed 15 May 2023.